Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).

Subjects

Subjects :

Humans
Receptors, Chimeric Antigen
COVID-19
Leukemia complications
Leukemia therapy
Hematologic Neoplasms complications
Hematologic Neoplasms therapy
Hematopoietic Stem Cell Transplantation adverse effects

Details

Language :

English

ISSN :

1476-5551

Volume :

37

Issue :

9

Database :

MEDLINE

Journal :

Leukemia

Publication Type :

Editorial & Opinion

Accession number :

37460673

Full Text :

https://doi.org/10.1038/s41375-023-01938-5